Abstract
A discovery is meaningless if the findings are not published in a scientific or medical journal. Publishing in a journal is not an easy process. There are a limited number of medical journals, and the number of the many articles submitted for consideration for publication far exceeds the journal space available. It has been stated that less than 5% of articles submitted are published and more than 95% are rejected. There is just not enough space to accommodate all the articles that are submitted. On the other hand, there is tremendous pressure to publish. Publish or perish is a well-known fact. Unfortunately, a substantial amount of research just does not get published.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158–161.
Barza MJ. Detection of Chlamydia pneumoniae. In: Keusch GT, Woolf SM (eds) Coronary arterial fatty streaks and atheromatous plaques. Year book of infectious diseases. St. Louis: Mosby, 1994:365–367.
Kuo C-C, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841–849.
Shor A, Brunton JG, Van Sittert GCH. Preliminary study of structures found in human coronary artery lesions. Electron Microscopic Society of South Africa, Cape Town, December 1991, pp 241–242.
Shor A. Chlamydia TWAR in coronary atheroma: an ultrastructural study. Presented at 31st Annual Congress of Society of Pathology of South Africa, 30 June to 3 July, 1991, Warmbaths, South Africa.
Shor A, Kuo C-C, Patton DL, et al. Detection of Chlamydia pneumoniae in coronary atheroma plaque. Presented at 92nd American Society of Microbiology Meeting, 26–30 May, 1992, New Orleans, LA, USA.
Shor A, Pantanowitz D, Veller M, et al. New avenues of research in Chlamydia related atheroma. Presented at 20th Biennial Congress of Southern Africa, 31 August–5 September, 1996, Victoria Falls, Zimbabwe.
Shor A. Treatment of chlamydial atherosclerotic lesions. In: Abstracts of 2nd International Meeting of Interventional Cardiology, Jerusalem, Israel, June–July 1997. J Invas Cardiol 1997;9(suppl C).
Shor A, Pantanowitz D, Veller M. The current status of the association between Chlamydia pneumoniae and atherosclerosis. Presented to the Vascular Society of Southern Africa, Sun City, 1–4 August, 1999.
Shor A. Atherosclerosis: role of Chlamydia pneumoniae in atherogenesis and lipid production. Presented at LASSA Congress, 2–7 April, 2000, Durban, South Africa.
Camm AJ, Grayston JT. Chlamydia pneumoniae in the cardiovascular system. Atherosclerosis (Suppl) 1998;140:S1–S35.
Campbell LA, Kuo C-C, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 1998;l4(4):571–579.
Gaydos CA. Chlamydia pneumoniae: a review and evidence in coronary artery disease. Clin Microbiol Newsl 1995;17(7):49–54.
Grayston JT, Kuo C-C, Campbell LA, et al. Chlamydia pneumoniae strain TWAR and atherosclerosis. Eur Heart J 1993;14(suppl K):66–71.
Grayston JT. Chlamydia in atherosclerosis. Circulation 1993;87(4):1408–1409.
Grayston JT. Does Chlamydia pneumoniae cause atherosclerosis? Arch Surg 1999;134:930–934.
Ewald PW, Cochran GM. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infection and antibiotic treatment. J Infect Dis (Suppl) 2000;181(30):S394–S401.
Taylor-Robinson D. Chlamydia pneumoniae in vascular tissue. Atherosclerosis 1998;140(suppl 1):s21–s24.
Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol 1998;51:793–797.
Quinn CT. Does Chlamydia pneumoniae cause coronary heart disease? Curr Opin Infect Dis 1998;11:301–307.
Veller M, Shor A. The role of Chlamydia pneumoniae in the pathogenesis of atherosclerosis. Eur J Endovasc Surg 1998;16:459–461.
Kuo C-C, Campbell LA. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today 1998;4:426–430.
Muhlestein JB. The link between Chlamydia pneumoniae and atherosclerosis. Infect Med 1997;14(5):380–382.
Zeeman K, Pospisil L, Canderle J, et al Direct and indirect evidence of Chlamydia pneumoniae in patients with significant stenosis of a carotis of atherosclerotic origin. Scripta Med (BRNO) 2004;77(3):173–180.
Rose AG. Chlamydia pneumoniae and atherosclerosis. (Editorial). Cardiovasc J S Afr 2000;11(1):11–12.
Ramirez JA and the Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979–982.
Jackson LA, Campbell LA, Kuo C-C, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176(19):292–295.
Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998;31:827–832.
Apfalter P, Loidl M, Nadrchal R, et al. Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens. Eur J Clin Microbiol Infect Dis 2000;19:305–308.
Karlsson L, Gnarpe J, Naas J, et al. Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000;19(6):630–635.
Gieffers J, Durling L, Ouellette SP, et al. Genotypic differences in the Chlamydia pneumoniae tyr P gene related to vascular tropism and pathogenicity. J Infect Dis 2003;188(8):1085–1093.
Jantos CA, Heck S, Roggendorf R, et al. Antigenic and molecular analyses of different Chlamydia pneumoniae strains. J Clin Microbiol 1997;35(3):620–623.
Kalman S, Mitchell W, Marathe R, et al. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet 1999;21:385–389.
Karunakaran KP, Blanchard JF, Raudonikiene A, et al. Molecular and seroepidemiology of Chlamydia pneumoniae bacteriophage (Cpn1). J Clin Microbiol 2002;40(11):4010–4014.
Kutlin A, Flegg C, Stenzel D, et al. Ultrastructural study of Chlamydia pneumoniae in a continuous model. J Clin Microbiol 2001;39:3721–3723.
Molestina RE, Dean D, Miller RD, et al. Characterisation of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analyses of the Omp 1 gene and biological activity in human endothelial cells. Infect Immun 1998;66(4):1370–1376.
Osserwaarde JM, Meijer A. Molecular evidence for existence of additional members of order Chlamydiales. Microbiology 1999;145(pt 2):411–417.
Read TD, Brunham RC, Shen SR, et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000;25:1397–1406.
Shirai M, Hirakawa H, Kimoto M, et al. Comparison of whole genome sequence of Chlamydia pneumoniae J138 from Japan and CWL029 from U.S.A. Nucleic Acids Res 2000;28:2311–2314.
Everett KD, Bush RM, Andersen AA. Amended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov. containing one monocytic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999;49(pt 2):415–440.
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2007). Publications, Presentations, and Confirmation. In: Chlamydia Atherosclerosis Lesion. Springer, London. https://doi.org/10.1007/978-1-84628-810-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-84628-810-4_8
Publisher Name: Springer, London
Print ISBN: 978-1-84628-809-8
Online ISBN: 978-1-84628-810-4
eBook Packages: MedicineMedicine (R0)